GCG and metabolic syndrome: The aim of the current study was to evaluate fasting serum sCD26/DPP-IV levels and active GLP-1 levels in Malaysian T2DM patients with and without MetS, as well as to investigate the association of sCD26/DPP-IV level with MetS parameters and antidiabetic agents.